Open House Original Discount Agreements 2025-25 - Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid
Original notice title
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-25 - Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid (Wirkstoffkombination)
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
No guaranteed purchase volumes; revenue depends on market uptake.
Legal recourse is to social courts, not procurement review bodies; may be unfamiliar.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Oct 2027
- Conclusion of discount agreements for the supply of Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid (HIV drug combination) to TK and participating insurance funds.
- Contractual terms are non-negotiable and uniform for all participants.
Show full summary
Open House procedure by Techniker Krankenkasse (TK) to conclude discount agreements (Rabattverträge) for the active ingredient combination Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid. All eligible pharmaceutical entrepreneurs can join at any time during the contract period. No competitive selection; contracts are concluded with all meeting the eligibility criteria. Contract duration max 24 months from 01.11.2025 to 31.10.2027, with early termination upon patent expiry. No estimated value provided.
Risks
No guaranteed purchase volumes; revenue depends on market uptake.
Legal recourse is to social courts, not procurement review bodies; may be unfamiliar.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG with respect to the offered drug.
- Must hold a valid marketing authorization for the drug combination or be entitled to place it on the market.
- Must have seat in Germany, another EU Member State, or EEA state (§9 Abs. 2 AMG).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open House Original Discount Agreements 2025-25 - Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid
Single lot for discount agreements on the specified HIV drug combination. Open to all eligible pharmaceutical entrepreneurs. No exclusivity, uniform conditions.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria - all eligible participants are accepted.
Value note
Show original TED data
Original lot title
Open House Originale Rabattverträge 2025-25 - Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid (Wirkstoffkombination)
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zur Wirkstoffkombination Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid zu schließen.
Procurement Details
- Publication date
- 21 Aug 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 548037-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
No guaranteed purchase volumes; revenue depends on market uptake.
Legal recourse is to social courts, not procurement review bodies; may be unfamiliar.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications